Iovance Biotherapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 4.06, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Iovance Biotherapeutics Inc in Sep 30 2026 quarter, has decreased to 90 days, compared to 94 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 442 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 1785 to 2880.

What is Receivable Turnover Ratio?
What is Iovance Biotherapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IOVA Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	60.26 %	70.37 %	15.25 %	18.9 %	19.71 %
Y / Y Revenue Change	80.07 %	65.65 %	44.82 %	17.74 %	15.2 %
Receivable Turnover Ratio (TTM)	4.06	3.9	3.93	3.76	3.75
IOVA's Total Ranking	# 2880	# 1785	# 2372	# 2515	#
Accounts Receivable average collection period days	90	94	93	97	97
Seq. Receivable Change	4.77 %	24.9 %	-0.84 %	23.5 %	11.38 %
Seq. Revenue Change	22.31 %	39.04 %	-17.68 %	28.64 %	12.52 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 47
Healthcare Sector	# 443
Overall Market	# 2880

Receivable Turnover Ratio Statistics
High	Average	Low
18.22	5.35	3.74
(Mar 31 2024)		(Mar 31 2025)

IOVA Company Profile • Back to IOVA Efficiency Comparisons • Compare IOVA Receivables Turnover Ratio to its Competitors

Financial Statements
Iovance Biotherapeutics Inc 's Accounts Receivable	$ 107 Millions	Visit IOVA's Balance sheet
Iovance Biotherapeutics Inc 's Sales TTM	$ 379 Millions	Visit IOVA's Income Statement
Sources of IOVA's Revenues		Visit IOVA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
IOVA's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
IOVA's Growth Rates	IOVA's Roa	IOVA's Inventory Turnover Ratio	IOVA's Dividend Comparisons
IOVA's Profitability Ratios	IOVA's Roi	IOVA's Asset Turnover Ratio	IOVA's Dividend Growth
IOVA's Valuation Ratios	IOVA's Roe	IOVA's Financial Strength Ratios	IOVA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Myomo Inc	9.66	$ 47.775 Millions	$ 4.947 Millions
Encompass Health Corporation	9.41	$ 6,338.100 Millions	$ 673.625 Millions
Bausch Health Companies Inc	9.15	$ 11,113.000 Millions	$ 1,215.000 Millions
Co diagnostics Inc	9.12	$ 0.859 Millions	$ 0.094 Millions
Pacs Group Inc	8.88	$ 5,705.049 Millions	$ 642.729 Millions
Lexicon Pharmaceuticals Inc	8.77	$ 38.537 Millions	$ 4.396 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Avita Medical Inc	8.65	$ 84.683 Millions	$ 9.795 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Pediatrix Medical Group Inc	8.57	$ 1,959.124 Millions	$ 228.471 Millions
Tenet Healthcare Corp	8.54	$ 22,154.000 Millions	$ 2,593.250 Millions
Brightspring Health Services Inc	8.50	$ 9,479.144 Millions	$ 1,114.763 Millions
Sotera Health Company	8.49	$ 1,230.250 Millions	$ 144.974 Millions
Acadia Pharmaceuticals Inc	8.46	$ 1,202.301 Millions	$ 142.117 Millions
Novavax inc	8.33	$ 411.649 Millions	$ 49.414 Millions
Tactile Systems Technology Inc	8.23	$ 357.176 Millions	$ 43.385 Millions
Penumbra Inc	8.22	$ 1,560.334 Millions	$ 189.735 Millions
Tela Bio Inc	8.16	$ 79.525 Millions	$ 9.743 Millions
Inspire Medical Systems inc	8.15	$ 882.194 Millions	$ 108.207 Millions
Adapthealth Corp	8.14	$ 3,152.043 Millions	$ 387.280 Millions
Sonoma Pharmaceuticals Inc	8.05	$ 23.490 Millions	$ 2.918 Millions
Rhythm Pharmaceuticals Inc	8.03	$ 280.748 Millions	$ 34.950 Millions
Protalix Biotherapeutics inc	8.03	$ 84.693 Millions	$ 10.549 Millions
Alphatec Holdings Inc	7.91	$ 839.652 Millions	$ 106.153 Millions
Exelixis Inc	7.89	$ 2,496.861 Millions	$ 316.636 Millions
Koru Medical Systems Inc	7.84	$ 46.272 Millions	$ 5.901 Millions
Henry Schein Inc	7.84	$ 13,734.000 Millions	$ 1,752.000 Millions
Trisalus Life Sciences Inc	7.78	$ 47.397 Millions	$ 6.090 Millions
Idexx Laboratories Inc	7.78	$ 4,663.675 Millions	$ 599.701 Millions
Anteris Technologies Global Corp	7.73	$ 2.332 Millions	$ 0.302 Millions

Date modified: 2026-11-09T06:45:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.